These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29874192)

  • 21. Procalcitonin in special patient populations: Guidance for antimicrobial therapy.
    Smith SE; Muir J; Kalabalik-Hoganson J
    Am J Health Syst Pharm; 2020 May; 77(10):745-758. PubMed ID: 32340027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 26. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations.
    Kwa AL; Aninda Sidharta BR; Son DN; Zirpe K; Periyasamy P; Plongla R; Swaminathan S; Loho T; Van Giap V; Apisarnthanarak A
    Expert Rev Anti Infect Ther; 2024; 22(1-3):45-58. PubMed ID: 38112181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin: Between evidence and critical issues.
    Aloisio E; Dolci A; Panteghini M
    Clin Chim Acta; 2019 Sep; 496():7-12. PubMed ID: 31194966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.
    Schuetz P; Bretscher C; Bernasconi L; Mueller B
    Expert Rev Mol Diagn; 2017 Jun; 17(6):593-601. PubMed ID: 28443360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.
    Fantoni M; Taddei E; Cauda R; Antonelli Incalzi R; Capone A; Cortese F; Sanguinetti M; Spandonaro F; Urbani A; Murri R
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2978-2985. PubMed ID: 31002168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin as a biomarker for critically ill patients with sepsis: Effects of vitamin D supplementation.
    Wolf TA; Wimalawansa SJ; Razzaque MS
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105428. PubMed ID: 31323346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An algorithm for PCT-guided antimicrobial therapy: a consensus statement by Japanese experts.
    Ito A; Shime N; Fujishima S; Fujitani S; Komiya K; Schuetz P
    Clin Chem Lab Med; 2023 Feb; 61(3):407-411. PubMed ID: 36453810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Procalcitonin (PCT) guidance for antibiotics management of adult sepsis patients in the Egyptian context.
    Mosly MM; Mousli HM; Ahmed IMM; Abdou MIA
    BMC Health Serv Res; 2024 Oct; 24(1):1249. PubMed ID: 39420348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.